These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7461859)

  • 1. Hemodialysis of acetaminophen in uremic patients.
    Marbury TC; Wang LH; Lee CS
    Int J Artif Organs; 1980 Sep; 3(5):263-6. PubMed ID: 7461859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance calculations in hemodialysis: application to blood, plasma, and dialysate measurements for ethambutol.
    Lee CS; Marbury TC; Benet LZ
    J Pharmacokinet Biopharm; 1980 Feb; 8(1):69-81. PubMed ID: 7381692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of dyphylline elimination by uremic patients.
    Lee CC; Wang LH; Majeske BL; Marbury TC
    J Pharmacol Exp Ther; 1981 May; 217(2):340-4. PubMed ID: 7229976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance and recovery calculations in hemodialysis: application to plasma, red blood cells, and dialysate measurements for cyclophosphamide.
    Wang LH; Lee CS; Majeske BL; Marbury TC
    Clin Pharmacol Ther; 1981 Mar; 29(3):365-72. PubMed ID: 7471607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of primidone elimination by uremic patients.
    Lee CS; Marbury TC; Perchalski RT; Wilder BJ
    J Clin Pharmacol; 1982 Jul; 22(7):301-8. PubMed ID: 7107978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodialysis clearance and total body elimination of carbamazepine during chronic hemodialysis.
    Lee CS; Wang LH; Marbury TC; Bruni J; Perchalski RJ
    Clin Toxicol; 1980 Oct; 17(3):429-38. PubMed ID: 7449356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodialysis clearance of chloroquine in uremic patients.
    Akintonwa A; Odutola TA; Edeki T; Mabadeje AF
    Ther Drug Monit; 1986; 8(3):285-7. PubMed ID: 3750371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodialysis of theophylline in uremic patients.
    Lee CS; Marbury TC; Perrin JH; Fuller TJ
    J Clin Pharmacol; 1979 Apr; 19(4):219-26. PubMed ID: 438357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis of mefenamic acid in uremic patients.
    Wang LH; Lee CS; Marbury TC
    Am J Hosp Pharm; 1980 Jul; 37(7):956-8. PubMed ID: 7395889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radionuclide method for evaluating the performance of hemodialysis in vivo.
    Bihl GR; Bird NJ; Peters C; Bradley JR; Peters AM
    Kidney Int; 2005 Feb; 67(2):721-31. PubMed ID: 15673322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption and disposition of ibuprofen in hemodialyzed uremic patients.
    Senekjian HO; Lee CS; Kuo TH; Au DS; Krothapalli R
    Eur J Rheumatol Inflamm; 1983; 6(2):155-62. PubMed ID: 6673979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodialysis clearance of ethosuximide in patients with chronic renal disease.
    Marbury TC; Lee CS; Perchalski RJ; Wilder BJ
    Am J Hosp Pharm; 1981 Nov; 38(11):1757-60. PubMed ID: 7304633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis-associated platelet loss: study of the relative contribution of dialyzer membrane composition and geometry.
    Docci D; Turci F; Del Vecchio C; Bilancioni R; Cenciotti L; Pretolani E
    Int J Artif Organs; 1984 Nov; 7(6):337-40. PubMed ID: 6526528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of phenytoin by hemodialysis in uremic patients.
    Martin E; Gambertoglio JG; Adler DS; Tozer TN; Roman LA; Grausz H
    JAMA; 1977 Oct; 238(16):1750-3. PubMed ID: 578272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hemodialysis on kinetics of acetaminophen elimination by anephric patients.
    Oie S; Lowenthal DT; Briggs WA; Levy G
    Clin Pharmacol Ther; 1975 Dec; 18(6):680-6. PubMed ID: 1204276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodialysis of phenytoin in a uremic patient.
    Adler DS; Martin E; Gambertoglio JG; Tozer TN; Spire JP
    Clin Pharmacol Ther; 1975 Jul; 18(1):65-9. PubMed ID: 1149364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of felodipine in chronic hemodialysis patients.
    Buur T; Larsson R; Regårdh CG; Aberg J
    J Clin Pharmacol; 1991 Aug; 31(8):709-13. PubMed ID: 1880229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of neutrophil apoptosis by uremic plasma during hemodialysis.
    Jaber BL; Balakrishnan VS; Cendoroglo MN; Perianayagam MC; King AJ; Pereira BJ
    Blood Purif; 1998; 16(6):325-35. PubMed ID: 10343079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPLC study of uremic fluids related to optical dialysis adequacy monitoring.
    Lauri K; Tanner R; Jerotskaja J; Luman M; Fridolin I
    Int J Artif Organs; 2010 Feb; 33(2):96-104. PubMed ID: 20306436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.